Reuben Harris, PhD of University of Minnesota, Minneapolis, MN discusses APOBEC mutagenesis, which occurs in almost half of human cancers. In some cancer types almost all mutations are attributable to this source of mutation. Other cancer types may be less affected, but Dr Harris points out that this knowledge could be used moving forward when new therapies are designed. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates